InfuSystem Holdings, Inc

For the period ended Dec 31, 2025. Filed Feb 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 27, 2026

INFU$13.69+1.0%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INFUSYSTEM HOLDINGS, INC.
Date: February 27, 2026	By:	/s/ CARRIE LACHANCE
		Carrie Lachance
		Chief Executive Officer and Director(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacity and on the dates indicated.

Date: February 27, 2026	By:	/s/ CARRIE LACHANCE
		Carrie Lachance
		Chief Executive Officer and Director(Principal Executive Officer)
Date: February 27, 2026		/s/ BARRY STEELE
		Barry Steele
		Chief Financial Officer(Principal Accounting and Financial Officer)
Date: February 27, 2026		/s/ SCOTT SHUDA
		Scott Shuda
		Chairman of the BoardDirector
Date: February 27, 2026		/s/ KENNETH EICHENBAUM
		Kenneth Eichenbaum
		Director
Date: February 27, 2026		/s/ PAUL GENDRON
		Paul Gendron
		Director
Date: February 27, 2026		/s/ BEVERLY HUSS
		Beverly Huss
		Director
Date: February 27, 2026		/s/ RONALD HUNDZINSKI
		Ronald Hundzinski
		Director
Date: February 27, 2026		/s/ DR. JOHN J. SVIOKLA
		Dr. John J. Sviokla
		Director

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.